The psychological impact of therapeutic changes during the COVID-19-lockdown for gynaecological and breast cancer patients
- PMID: 35007776
- PMCID: PMC8739811
- DOI: 10.1016/j.jogoh.2022.102311
The psychological impact of therapeutic changes during the COVID-19-lockdown for gynaecological and breast cancer patients
Abstract
Objective: The exceptional health situation related to the Coronavirus 2019 (COVID-19) pandemic has required an in-depth and immediate reorganisation of gynaecological cancer care. The main objective was to assess the psychological impact of such treatment modifications during the lockdown period for gynaecological and breast cancer patients.
Patients and methods: A multicentre prospective study was conducted in three university gynaecological cancer wards (Hospices Civils de Lyon, France) during the French first lockdown (16th March to 11th May 2020). All patients with non-metastatic breast cancer or gynaecological cancer were included. Data was collected regarding treatment modifications (delay, cancellation, change of therapeutic plan). The psychological impact of treatment modifications during and after the lockdown was assessed by validated questionnaires (SF-12, EORTC-QLQ-C30, HADS).
Results: A total of 205 consecutive patients were included, aged 60.5 ± 1.0 years. Seven patients (3.4%) presented a SARS-CoV-2 infection, and two patients died. Treatment was maintained for 122 (59.5%) patients, postponed for 72 (35.1%) and cancelled for 11 (5.4%). During the lockdown, 35/118 (29.7%) patients suffered from confirmed anxiety and the mean fatigue-EORTC score was 48.00 ± 2.51; it was 38.64 ± 2.33 (p = 0.02) after the lockdown. After the lockdown and compared to the lockdown period, the mental SF-12 score and overall health status EORTC score were significantly higher (45.03 ± 1.06 vs 41.71 ± 1.15, p = 0.02 and 64.58 ± 1.66 vs 57.44 ± 2.02, p = 0.0007, respectively). The number of confirmed-anxiety cases was significantly higher amongst patients for whom treatment was delayed or cancelled (40.5% vs 23.7%, p = 0.04).
Conclusion: This study quantified the treatment modifications of gynaecological cancer patients during the COVID-19 lockdown and revealed a poorer psychological state and quality of life during this period, even for patients whose treatment plan was not actually modified. Anxiety was more significant in patients with a delayed or cancelled treatment.
Keywords: COVID-19 pandemic; Gynaecological cancer; Psychological symptoms; SARS-CoV-2; breast cancer.
Copyright © 2022 Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
[Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].Gynecol Obstet Fertil Senol. 2020 Nov;48(11):777-783. doi: 10.1016/j.gofs.2020.09.011. Epub 2020 Sep 30. Gynecol Obstet Fertil Senol. 2020. PMID: 33010487 Free PMC article. French.
-
Impact of the first lockdown for coronavirus 19 on breast cancer management in France: A multicentre survey.J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102166. doi: 10.1016/j.jogoh.2021.102166. Epub 2021 May 24. J Gynecol Obstet Hum Reprod. 2021. PMID: 34033966 Free PMC article.
-
Physical and mental health of breast cancer patients and survivors before and during successive SARS-CoV-2-infection waves.Qual Life Res. 2023 Aug;32(8):2375-2390. doi: 10.1007/s11136-023-03400-6. Epub 2023 Apr 4. Qual Life Res. 2023. PMID: 37016089 Free PMC article.
-
Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors.JNCI Cancer Spectr. 2020 Nov 5;5(1):pkaa104. doi: 10.1093/jncics/pkaa104. eCollection 2021 Feb. JNCI Cancer Spectr. 2020. PMID: 33437925 Free PMC article.
-
Cellular Landscaping of COVID-19 and Gynaecological Cancers: An Infrequent Correlation.J Oncol. 2022 Oct 17;2022:5231022. doi: 10.1155/2022/5231022. eCollection 2022. J Oncol. 2022. PMID: 36299504 Free PMC article. Review.
Cited by
-
Prioritizing Melanoma Surgeries to Prevent Wait Time Delays and Upstaging of Melanoma during the COVID-19 Pandemic.Curr Oncol. 2023 Sep 9;30(9):8328-8337. doi: 10.3390/curroncol30090604. Curr Oncol. 2023. PMID: 37754519 Free PMC article.
-
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.Adv Ther. 2025 Feb;42(2):666-719. doi: 10.1007/s12325-024-03043-0. Epub 2024 Dec 16. Adv Ther. 2025. PMID: 39680311 Free PMC article. Review.
-
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.Oncologist. 2025 Jun 4;30(6):oyaf074. doi: 10.1093/oncolo/oyaf074. Oncologist. 2025. PMID: 40525910 Free PMC article. Review.
-
The Experience of COVID-19 in a Sample of Gynecological Cancer Patients Undergoing Chemotherapy: A Focus on the Psychological Implications.Int J Environ Res Public Health. 2023 Feb 21;20(5):3851. doi: 10.3390/ijerph20053851. Int J Environ Res Public Health. 2023. PMID: 36900862 Free PMC article.
-
Impact of the COVID-19 Lockdown on Physical Activity Levels and Health Parameters in Young Adults with Cancer.Curr Oncol. 2023 Jun 2;30(6):5395-5408. doi: 10.3390/curroncol30060409. Curr Oncol. 2023. PMID: 37366892 Free PMC article.
References
-
- WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 March 2020. n.d. https://www.who.int/fr/director-general/speeches/detail/who-director-gen... (accessed August 3, 2021).
-
- LOI n° 2020-290 du 23 mars 2020 d'urgence pour faire face à l’épidémie de covid-19 (1). 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous